[ABCL] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[ABCL] AbCellera Biologics Inc.
Announcement Date
29-Sep-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -140.18%
YoY- -7,580.56%
Quarter Report
ABCL's Result
ABCL's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 27,643 202,741 207,908 9,362 11,228 4,657 3,202 321.38%
PBT -2,073 161,487 155,915 -2,693 6,703 -2,093 -1,641 16.87%
Tax 250 44,266 39 0 0 0 82 110.40%
NP -2,323 117,221 117,000 -2,693 6,703 -2,093 -1,641 26.10%
Tax Rate - -27.41% -0.02% - 0.00% - - -
Total Cost 29,966 85,520 90,909 12,055 4,525 6,750 4,843 237.41%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -8.40 57.82 56.27 -28.77 59.70 -44.94 -51.24 -70.07%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.01 0.43 0.43 -0.01 0.03 -0.01 -0.01 0.00%
EPS Diluted -0.01 0.37 0.37 -0.01 0.03 -0.01 -0.01 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.